AlphaStocks
4.4
Weak

Teleflex Inc (TFX)

As of Sep 20, 2026, Teleflex Inc (TFX) scores 4.4/10 on AlphaStocks' five-model composite, #129 of 168 Health Care stocks. At $125, TFX trades 12% above its model fair value of $111.

Health Care / Health Care Equipment

S&P SmallCap 600

$124.53

Below average on several measures. Research carefully.

Weak

Score based on 4 of 5 models — moderate confidence

Data as of Sep 20, 2026

#129out of 168 in Health Care

Is TELEFLEX INC a Good Investment in 2026?

TELEFLEX INC (TFX) scores 4.4 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model is the most favorable, rating TELEFLEX INC as Neutral. However, the Greenblatt Magic Formula model rates it Caution — Earnings yield 1.4% · ROC 7%. TELEFLEX INC currently trades 12% above its estimated fair value of $111. TELEFLEX INC ranks #129 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

ROE-25.8Market Cap6BDiv Yield1.0

Estimated Fair Value

$110.7512% above

Trading above estimated fair value — the market may be pricing in future growth.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Neutral

3/9

Buffett

Caution

Business quality & competitive moat

Graham

Neutral

Price vs intrinsic value

Lynch

Limited Data

Growth rate vs price (PEG)

Greenblatt

Caution

Earnings yield 1.4% · ROC 7%

Frequently Asked Questions

Is TELEFLEX INC (TFX) a good investment?
As of Sep 20, 2026, Teleflex Inc (TFX) scores 4.4/10 on AlphaStocks' five-model composite, #129 of 168 Health Care stocks. At $125, TFX trades 12% above its model fair value of $111. That score is below average, suggesting caution.
What is TELEFLEX INC's Piotroski F-Score?
TELEFLEX INC's Piotroski F-Score status is Neutral. The raw score is 3/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is TFX overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $111, TFX appears overvalued. The stock currently trades 12% above its estimated fair value. Trading above estimated fair value — the market may be pricing in future growth.
How does TFX compare to other Health Care stocks?
TELEFLEX INC ranks #129 out of 168 stocks in the Health Care sector, placing it in the top 77% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about TFX?
AlphaStocks evaluates TFX using five proven investment models. Piotroski: Neutral; Buffett: Caution; Graham: Neutral; Greenblatt Magic Formula: Caution. These models are combined into a single composite score of 4.4/10.

Similar Stocks

INSPUFPTBDX

Compare TFX with

INSP vs TFXTFX vs UFPTBDX vs TFXPARR vs TFX

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer